A Cell Model of Human Small Intestinal Wall Based on Genetically Modified Caco-2 Cells

Area of Science:

• Cell Biology
• Toxicology
• Gastroenterology

Background:

• The human small intestinal wall's response to toxins is crucial for understanding gastrointestinal health.
• Assessing the integrity and activation pathways of intestinal epithelial cells is vital for toxicology studies.

Purpose of the Study:

• To develop and validate a genetically modified Caco-2 cell model for studying the human small intestinal wall.
• To quantitatively assess the activation of the nuclear factor kappa B (NF-κB) pathway and related intracellular signaling.
• To correlate cellular pathway activation with functional changes in epithelial barrier integrity.

Main Methods:

• Utilized genetically modified Caco-2 cells to create a human small intestinal wall model.
• Employed fluorescence microscopy for visualization and quantitative assessment of NF-κB activation.
• Measured transepithelial electrical resistance (TEER) to assess monolayer integrity.
• Exposed cells to tumor necrosis factor-alpha (TNFα) at varying concentrations (1-100 ng/ml).

Main Results:

• Demonstrated a dose-dependent increase in fluorescence intensity, indicating NF-κB pathway activation in response to TNFα.
• Observed a correlation between increased fluorescence and a decrease in transepithelial resistance.
• The cell model successfully visualized and quantified intracellular pathway activation.

Conclusions:

• The developed Caco-2 cell model allows for effective visualization and quantification of NF-κB activation in the human small intestinal epithelium.
• This model provides a reliable method for assessing the toxic effects of substances on intestinal epithelial cells.
• The correlation between NF-κB activation and barrier function decrease offers a new metric for toxicological evaluation.